| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lymphoma, Large B-Cell, Diffuse | 18 | 2023 | 1664 | 2.580 |
Why?
|
| Lymphoma, Mantle-Cell | 15 | 2019 | 713 | 2.160 |
Why?
|
| NF-kappa B | 15 | 2016 | 1549 | 1.090 |
Why?
|
| NFATC Transcription Factors | 6 | 2018 | 96 | 1.010 |
Why?
|
| B-Cell Activation Factor Receptor | 3 | 2011 | 24 | 0.860 |
Why?
|
| Proto-Oncogene Proteins c-myc | 8 | 2023 | 810 | 0.810 |
Why?
|
| Karyopherins | 3 | 2020 | 136 | 0.730 |
Why?
|
| Gene Expression Regulation, Leukemic | 3 | 2018 | 560 | 0.680 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 6 | 2023 | 1493 | 0.640 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2018 | 171 | 0.610 |
Why?
|
| Lymphoma, B-Cell | 7 | 2023 | 895 | 0.600 |
Why?
|
| Azaserine | 1 | 2016 | 5 | 0.600 |
Why?
|
| Hexosamines | 1 | 2016 | 25 | 0.590 |
Why?
|
| Acetylglucosamine | 1 | 2016 | 25 | 0.590 |
Why?
|
| Organotechnetium Compounds | 1 | 2016 | 44 | 0.590 |
Why?
|
| Signal Transduction | 14 | 2019 | 11965 | 0.580 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 3 | 2020 | 591 | 0.580 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2016 | 46 | 0.580 |
Why?
|
| RNAi Therapeutics | 1 | 2016 | 42 | 0.570 |
Why?
|
| Cell Line, Tumor | 23 | 2020 | 14551 | 0.540 |
Why?
|
| Cysteine | 1 | 2016 | 214 | 0.540 |
Why?
|
| Cell Proliferation | 11 | 2018 | 7226 | 0.510 |
Why?
|
| B7-H1 Antigen | 2 | 2019 | 1022 | 0.500 |
Why?
|
| B-Lymphocytes | 8 | 2016 | 1294 | 0.480 |
Why?
|
| Macrophage Activation | 1 | 2014 | 148 | 0.470 |
Why?
|
| Cyclin D1 | 4 | 2018 | 576 | 0.470 |
Why?
|
| Triazoles | 2 | 2020 | 617 | 0.450 |
Why?
|
| Gene Expression Regulation, Neoplastic | 16 | 2020 | 8873 | 0.450 |
Why?
|
| Boronic Acids | 4 | 2012 | 362 | 0.450 |
Why?
|
| Acrylates | 1 | 2012 | 30 | 0.440 |
Why?
|
| Nitriles | 2 | 2010 | 906 | 0.430 |
Why?
|
| Cell Survival | 9 | 2018 | 3045 | 0.420 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2018 | 923 | 0.420 |
Why?
|
| Pyrazines | 4 | 2012 | 495 | 0.410 |
Why?
|
| Thioredoxins | 1 | 2012 | 50 | 0.410 |
Why?
|
| Translocation, Genetic | 2 | 2019 | 1245 | 0.390 |
Why?
|
| Antineoplastic Agents | 9 | 2020 | 14289 | 0.380 |
Why?
|
| Mice, SCID | 8 | 2018 | 1869 | 0.370 |
Why?
|
| Contrast Media | 1 | 2016 | 1472 | 0.360 |
Why?
|
| Apoptosis | 11 | 2020 | 7591 | 0.350 |
Why?
|
| Drug Resistance, Neoplasm | 8 | 2019 | 5178 | 0.350 |
Why?
|
| CD40 Ligand | 2 | 2009 | 115 | 0.340 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 1879 | 0.340 |
Why?
|
| Sulfonamides | 1 | 2018 | 1823 | 0.340 |
Why?
|
| Neoplasm Proteins | 2 | 2018 | 3230 | 0.320 |
Why?
|
| Nuclear Pore | 1 | 2007 | 17 | 0.320 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 287 | 0.310 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2007 | 37 | 0.310 |
Why?
|
| Small Ubiquitin-Related Modifier Proteins | 1 | 2007 | 54 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 2007 | 47 | 0.310 |
Why?
|
| Macrophages | 1 | 2014 | 1304 | 0.310 |
Why?
|
| Transcriptional Activation | 3 | 2007 | 1070 | 0.290 |
Why?
|
| Mice, Inbred NOD | 3 | 2018 | 905 | 0.270 |
Why?
|
| STAT3 Transcription Factor | 3 | 2018 | 1121 | 0.260 |
Why?
|
| RNA, Small Interfering | 4 | 2012 | 2216 | 0.260 |
Why?
|
| Cell Nucleus | 6 | 2015 | 1620 | 0.250 |
Why?
|
| B-Cell Activating Factor | 4 | 2012 | 25 | 0.240 |
Why?
|
| Transfection | 4 | 2016 | 2944 | 0.230 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2003 | 45 | 0.230 |
Why?
|
| Immunophenotyping | 4 | 2017 | 1681 | 0.230 |
Why?
|
| Pyridines | 1 | 2010 | 1244 | 0.230 |
Why?
|
| Organic Chemicals | 1 | 2003 | 113 | 0.230 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 1399 | 0.220 |
Why?
|
| Blotting, Western | 4 | 2015 | 3536 | 0.220 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2017 | 2232 | 0.220 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2011 | 2390 | 0.220 |
Why?
|
| Sulfones | 1 | 2003 | 143 | 0.210 |
Why?
|
| Genes, myc | 2 | 2017 | 358 | 0.210 |
Why?
|
| Molecular Targeted Therapy | 4 | 2019 | 2330 | 0.210 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2020 | 3552 | 0.210 |
Why?
|
| Humans | 39 | 2023 | 261506 | 0.180 |
Why?
|
| Pyrazoles | 3 | 2019 | 1471 | 0.180 |
Why?
|
| Gene Expression Profiling | 6 | 2020 | 5159 | 0.180 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2018 | 1678 | 0.180 |
Why?
|
| Proteomics | 2 | 2018 | 1380 | 0.180 |
Why?
|
| Proteolysis | 2 | 2018 | 370 | 0.170 |
Why?
|
| NF-KappaB Inhibitor alpha | 3 | 2010 | 136 | 0.170 |
Why?
|
| Hydrazines | 1 | 2020 | 208 | 0.170 |
Why?
|
| Phosphorylation | 6 | 2017 | 4804 | 0.170 |
Why?
|
| Bortezomib | 4 | 2012 | 543 | 0.170 |
Why?
|
| SOXC Transcription Factors | 1 | 2018 | 53 | 0.170 |
Why?
|
| Pyrimidines | 4 | 2019 | 3518 | 0.160 |
Why?
|
| Immunoprecipitation | 3 | 2010 | 591 | 0.160 |
Why?
|
| I-kappa B Proteins | 3 | 2010 | 170 | 0.160 |
Why?
|
| Cell Cycle | 2 | 2003 | 2084 | 0.160 |
Why?
|
| Oncogene Protein v-akt | 1 | 2018 | 101 | 0.160 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2018 | 3821 | 0.160 |
Why?
|
| Animals | 14 | 2019 | 59536 | 0.160 |
Why?
|
| Oxidative Phosphorylation | 1 | 2019 | 253 | 0.150 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 2796 | 0.150 |
Why?
|
| Transplantation, Heterologous | 3 | 2015 | 1082 | 0.150 |
Why?
|
| Glycosylation | 1 | 2016 | 213 | 0.140 |
Why?
|
| RNA, Messenger | 4 | 2016 | 6150 | 0.140 |
Why?
|
| Transcription Factor RelA | 1 | 2016 | 184 | 0.140 |
Why?
|
| CD40 Antigens | 2 | 2007 | 104 | 0.140 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2015 | 47 | 0.140 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 7222 | 0.140 |
Why?
|
| Mice | 11 | 2019 | 34495 | 0.130 |
Why?
|
| Interleukin-10 | 1 | 2018 | 478 | 0.130 |
Why?
|
| Karyotyping | 2 | 2015 | 1022 | 0.130 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 3639 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 4938 | 0.130 |
Why?
|
| CTLA-4 Antigen | 1 | 2019 | 657 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-rel | 2 | 2015 | 27 | 0.120 |
Why?
|
| Morpholines | 1 | 2015 | 289 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 703 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2017 | 2054 | 0.120 |
Why?
|
| Antigens, Surface | 1 | 2014 | 295 | 0.110 |
Why?
|
| Nuclear Proteins | 3 | 2015 | 3343 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2017 | 4757 | 0.110 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 1 | 2012 | 21 | 0.110 |
Why?
|
| Flow Cytometry | 2 | 2017 | 3033 | 0.110 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2019 | 1048 | 0.110 |
Why?
|
| RNA Interference | 1 | 2016 | 1408 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 589 | 0.100 |
Why?
|
| Toxins, Biological | 1 | 2012 | 51 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 5 | 2010 | 3101 | 0.100 |
Why?
|
| Genes, rel | 2 | 2009 | 8 | 0.100 |
Why?
|
| Oligopeptides | 1 | 2013 | 429 | 0.100 |
Why?
|
| Baculoviral IAP Repeat-Containing 3 Protein | 1 | 2010 | 18 | 0.100 |
Why?
|
| Lymphoma | 1 | 2019 | 1467 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2010 | 22 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2012 | 392 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2010 | 39 | 0.100 |
Why?
|
| Deoxyribonuclease I | 1 | 2010 | 67 | 0.100 |
Why?
|
| Drug Synergism | 2 | 2012 | 1313 | 0.090 |
Why?
|
| Cyanoacrylates | 1 | 2010 | 41 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2018 | 2450 | 0.090 |
Why?
|
| Adenine | 3 | 2019 | 631 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 3 | 2007 | 5395 | 0.090 |
Why?
|
| DNA Damage | 1 | 2018 | 1954 | 0.090 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2010 | 202 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2018 | 2045 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2010 | 3154 | 0.090 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 15862 | 0.090 |
Why?
|
| Drug Design | 1 | 2012 | 375 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 2488 | 0.090 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2017 | 1756 | 0.090 |
Why?
|
| RNA Stability | 1 | 2009 | 125 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2010 | 5637 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2007 | 191 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2012 | 1555 | 0.080 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 760 | 0.080 |
Why?
|
| Cytoplasm | 2 | 2007 | 652 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 1165 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 2864 | 0.080 |
Why?
|
| Piperidines | 3 | 2019 | 1035 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 1399 | 0.080 |
Why?
|
| Immunologic Surveillance | 1 | 2007 | 60 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2010 | 434 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2009 | 250 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2007 | 184 | 0.080 |
Why?
|
| Gene Rearrangement | 3 | 2019 | 783 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 1 | 2007 | 126 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2007 | 323 | 0.070 |
Why?
|
| Chromosome Aberrations | 1 | 2014 | 1960 | 0.070 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 1162 | 0.070 |
Why?
|
| Protein Stability | 2 | 2018 | 370 | 0.070 |
Why?
|
| 14-3-3 Proteins | 1 | 2007 | 143 | 0.070 |
Why?
|
| Microscopy, Confocal | 2 | 2006 | 663 | 0.070 |
Why?
|
| Thalidomide | 1 | 2009 | 569 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2009 | 657 | 0.070 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 4821 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2015 | 5710 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2010 | 854 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2005 | 448 | 0.060 |
Why?
|
| Mutation | 4 | 2019 | 15179 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2007 | 507 | 0.060 |
Why?
|
| Base Sequence | 1 | 2010 | 4917 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2006 | 1538 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2003 | 94 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2003 | 149 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2003 | 227 | 0.060 |
Why?
|
| Prognosis | 5 | 2020 | 21713 | 0.060 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2003 | 110 | 0.060 |
Why?
|
| bcl-X Protein | 1 | 2003 | 196 | 0.060 |
Why?
|
| Female | 9 | 2018 | 141928 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2003 | 213 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2005 | 1764 | 0.050 |
Why?
|
| Models, Biological | 1 | 2010 | 3254 | 0.050 |
Why?
|
| Neoplastic Stem Cells | 1 | 2009 | 1443 | 0.050 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 10331 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 1073 | 0.050 |
Why?
|
| Protein Transport | 2 | 2016 | 734 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2016 | 575 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2005 | 1046 | 0.040 |
Why?
|
| Histone Deacetylase 2 | 1 | 2018 | 35 | 0.040 |
Why?
|
| Subcellular Fractions | 2 | 2009 | 201 | 0.040 |
Why?
|
| Histone Deacetylase 1 | 1 | 2018 | 62 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 2018 | 111 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2010 | 9180 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2006 | 2819 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2023 | 2074 | 0.040 |
Why?
|
| Inflammation | 1 | 2007 | 2522 | 0.040 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2018 | 275 | 0.040 |
Why?
|
| Histones | 2 | 2018 | 1466 | 0.040 |
Why?
|
| Protein Binding | 2 | 2018 | 3438 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2009 | 518 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2018 | 481 | 0.040 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2017 | 146 | 0.040 |
Why?
|
| Interleukins | 1 | 2018 | 325 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2010 | 5270 | 0.030 |
Why?
|
| Prednisone | 1 | 2019 | 984 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 10035 | 0.030 |
Why?
|
| Biopsy | 1 | 2003 | 3443 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 7548 | 0.030 |
Why?
|
| Vincristine | 1 | 2019 | 1511 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 803 | 0.030 |
Why?
|
| Piperazines | 1 | 2003 | 2101 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 1489 | 0.030 |
Why?
|
| Burkitt Lymphoma | 1 | 2017 | 335 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2017 | 324 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2012 | 1519 | 0.030 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2017 | 301 | 0.030 |
Why?
|
| Rituximab | 1 | 2019 | 1528 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2019 | 904 | 0.030 |
Why?
|
| Phenotype | 2 | 2019 | 6295 | 0.030 |
Why?
|
| Middle Aged | 5 | 2019 | 86204 | 0.030 |
Why?
|
| Chromatin | 1 | 2018 | 942 | 0.030 |
Why?
|
| Male | 6 | 2018 | 123000 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2019 | 1516 | 0.030 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 424 | 0.030 |
Why?
|
| Lymphoma, Follicular | 1 | 2017 | 587 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 3001 | 0.030 |
Why?
|
| Doxorubicin | 1 | 2019 | 3005 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2012 | 231 | 0.020 |
Why?
|
| Transcriptome | 1 | 2019 | 1859 | 0.020 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2009 | 37 | 0.020 |
Why?
|
| Tumor Protein p73 | 1 | 2009 | 105 | 0.020 |
Why?
|
| Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 60 | 0.020 |
Why?
|
| Precision Medicine | 1 | 2017 | 1154 | 0.020 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2019 | 1249 | 0.020 |
Why?
|
| Aged | 4 | 2017 | 70117 | 0.020 |
Why?
|
| ADP-ribosyl Cyclase 1 | 1 | 2009 | 141 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2014 | 1301 | 0.020 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2009 | 205 | 0.020 |
Why?
|
| S Phase | 1 | 2009 | 281 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 15193 | 0.020 |
Why?
|
| Clone Cells | 1 | 2009 | 555 | 0.020 |
Why?
|
| Aneuploidy | 1 | 2009 | 369 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 611 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2009 | 593 | 0.020 |
Why?
|
| NEDD8 Protein | 1 | 2007 | 22 | 0.020 |
Why?
|
| Thymidine | 1 | 2007 | 155 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 2007 | 211 | 0.020 |
Why?
|
| Cellular Senescence | 1 | 2009 | 382 | 0.020 |
Why?
|
| Ubiquitins | 1 | 2007 | 86 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2009 | 771 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 837 | 0.020 |
Why?
|
| Receptors, Interleukin | 1 | 2007 | 97 | 0.020 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 1282 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2007 | 266 | 0.020 |
Why?
|
| Telomere | 1 | 2009 | 505 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 445 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2019 | 3869 | 0.020 |
Why?
|
| Disease Progression | 1 | 2017 | 6682 | 0.020 |
Why?
|
| Pre-B Cell Receptors | 1 | 2005 | 5 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2006 | 193 | 0.020 |
Why?
|
| Ubiquitin | 1 | 2007 | 344 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 10001 | 0.020 |
Why?
|
| Immunoglobulin kappa-Chains | 1 | 2005 | 73 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2005 | 311 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2005 | 173 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2006 | 694 | 0.010 |
Why?
|
| Lymphocytes | 1 | 2009 | 1234 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12221 | 0.010 |
Why?
|
| MicroRNAs | 1 | 2017 | 2947 | 0.010 |
Why?
|
| Genes, abl | 1 | 2003 | 110 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2006 | 621 | 0.010 |
Why?
|
| Leukemia, Lymphoid | 1 | 2003 | 276 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2015 | 9244 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2003 | 471 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 251 | 0.010 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 1823 | 0.010 |
Why?
|
| Binding Sites | 1 | 2006 | 2171 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2003 | 621 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 1688 | 0.010 |
Why?
|
| Caspases | 1 | 2003 | 661 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2007 | 4143 | 0.010 |
Why?
|
| Imatinib Mesylate | 1 | 2003 | 1665 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 1390 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2005 | 4233 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 2003 | 941 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 6086 | 0.010 |
Why?
|
| Benzamides | 1 | 2003 | 1832 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2003 | 1094 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2005 | 6089 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 29902 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 2359 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 5114 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 6942 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 11538 | 0.000 |
Why?
|
| Adult | 1 | 2000 | 77950 | 0.000 |
Why?
|